𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Cost-Effectiveness of Primary versus Secondary Prophylaxis with Pegfilgrastim in Women with Early-Stage Breast Cancer Receiving Chemotherapy

✍ Scribed by Scott D. Ramsey; Zhimei Liu; Rob Boer; Sean D. Sullivan; Jennifer Malin; Quan V. Doan; Robert W. Dubois; Gary H. Lyman

Book ID
109078893
Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
205 KB
Volume
12
Category
Article
ISSN
1098-3015

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Cost-effectiveness of switching to exeme
Cost-effectiveness of switching to exemestane versus continued tamoxifen as adjuvant therapy for postmenopausal women with primary breast cancer
✍ Nancy A. Risebrough; Shailendra Verma; Maureen Trudeau; Nicole Mittmann πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 170 KB πŸ‘ 1 views

## Abstract ## BACKGROUND. Sequential tamoxifen/exemestane therapy reportedly improves disease‐free survival in women with primary breast cancer compared with continued tamoxifen therapy. The objective of the current study was to assess the cost‐effectiveness of switching to exemestane after 2 to